Author Question: When electric utilities are regulated using an average cost pricing rule, they will earn zero ... (Read 67 times)

Jkov05

  • Hero Member
  • *****
  • Posts: 556
When electric utilities are regulated using an average cost pricing rule, they will earn zero economic profit. Is the previous statement correct or incorrect? Why?
 
  What will be an ideal response?

Question 2

The value of the marginal product of labor is given by:
 
  A) the ratio of the marginal product of labor to the wage rate.
  B) the product of the marginal product of labor and the wage rate.
  C) the ratio of the marginal product of labor to the price of the final good produced.
  D) the product of the marginal product of labor and the price of the final good produced.



AISCAMPING

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

The statement is correct. An average cost pricing rule requires that the firm set its price equal to its average total cost. When price equals average total cost, the firm earns zero economic profit.

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Aspirin is the most widely used drug in the world. It has even been recognized as such by the Guinness Book of World Records.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library